Skip to content
Disclosery

EXANE DERIVATIVES: TUR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on TUR, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 13,559 TUR shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 13,559 shares
    Change vs previous 13F 0 shares

    0.15% of the 13F portfolio, value $257,704.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 13,559 shares
    Change vs previous 13F 0 shares

    0.08% of the 13F portfolio, value $280,677.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 13,559 shares
    Change vs previous 13F +13,500 shares

    0.06% of the 13F portfolio, value $251,938.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 59 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $1,254.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 59 shares
    Change vs previous 13F -197,956 shares

    <0.01% of the 13F portfolio, value $1,247.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 198,015 shares
    Change vs previous 13F +20,921 shares

    1.37% of the 13F portfolio, value $4,552,612.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 177,094 shares
    Change vs previous 13F -359,968 shares

    1.42% of the 13F portfolio, value $4,693,237.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 537,062 shares
    Change vs previous 13F not available

    3.46% of the 13F portfolio, value $10,612,631.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).